🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Phase I Split-Belt Treadmill Dosing for Subacute Stroke

RecruitingPhase 1Ages 18 Years - anyAllUniversity of Calgary
NCT07469163 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

After experiencing a stroke, many individuals encounter difficulties with walking and balance, which can significantly impact their independence. Recent studies have indicated that split-belt treadmill (SBT) training is effective for improving gait metrics, including walking speed and step length asymmetry. The SBT allows each leg to move at different speeds, which has been shown to help chronic stroke survivors learn to walk more symmetrically. However, there is limited knowledge about the dose participants should receive and the safety of SBT training in the early stages of recovery, which is a crucial period for rehabilitation. To address this gap, we are evaluating an innovative SBT with virtual reality (VR) features at the Foothills Medical Center. Our objective is to conduct a study to determine the amount of SBT training patients can tolerate in a day. In this study, stroke surviv

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ischemic or hemorrhagic stroke survivors * First stroke * Over 18 years old * Between one week and three months post-stroke * can understand task instructions. Exclusion Criteria: * History of significant neurological diseases (e.g. Multiple Sclerosis, Parkinson's disease) * Orthopedic issues in lower extremities (e.g. severe knee Osteoarthritis) * Excessive pain preventing participants from participating in treadmill-based activities * Cerebellar stroke * Body weight more than 560 lbs (this exceeds the weight limit of the support harness)
💊

What it tests

  • Split-Belt Treadmill
📍

Where

1 site
Foothills Hospital
Calgary, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy